Nine Point Two Capital LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 7,458 shares of ARWR stock, worth $190,701. This represents 0.09% of its overall portfolio holdings.
Number of Shares
7,458
Previous 7,458
-0.0%
Holding current value
$190,701
Previous $200,000
14.0%
% of portfolio
0.09%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$392 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$317 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$219 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$168 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$106 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.71B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...